Article

InterMEL: An international biorepository and clinical database to uncover predictors of survival in early-stage melanoma

2022-05-23

Abstract excerpt

<h4>Introduction</h4> We are conducting a multicenter study to identify classifiers predictive of disease-specific survival in patients with primary melanomas. Here we delineate the unique aspects, challenges, and best practices for optimizing a study of generally small-sized pigmented tumor samples including primary melanomas of at least 1.05mm from AJTCC TNM stage IIA-IIID patients. This ongoing study will targe...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 31f63bee-f004-5329-94d0-087ea65ff5f4
DOI: 10.1101/2022.05.21.22275329

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

InterMEL: An international biorepository and clinical database to uncover predictors of survival in early-stage melanomaDOI 10.1101/2022.05.21.22275329Read

Translation of a circulating microRNA signature of melanoma into a solid tissue assay to improve diagnostic accuracy and precision.Semantic proximity Read

Medical bioinformatics in melanomaSemantic proximity Read

Bioinformatic and Machine Learning Applications in Melanoma Risk Assessment and Prognosis: A Literature Review.Semantic proximity Read

Landscape of mutations in early stage primary cutaneous melanoma: An InterMEL study.Semantic proximity Read

Molecular Pathology of Skin Melanoma: Epidemiology, Differential Diagnostics, Prognosis and Therapy PredictionSemantic proximity Read

Melanoma subtypes: genomic profiles, prognostic molecular markers and therapeutic possibilitiesSemantic proximity Read

Molecular Frontiers in Melanoma: Pathogenesis, Diagnosis, and Therapeutic Advances.Semantic proximity Read

Classification of node-positive melanomas into prognostic subgroups using keratin, immune, and melanogenesis expression patternsSemantic proximity Read

Recognition, Staging, and Management of Melanoma.Semantic proximity Read

Advantages of MelArray over Oncomine Focus Assay for Mutation Analysis in Melanoma.Semantic proximity Read

Transcriptional dissection of melanoma identifies a high-risk subtype underlying TP53 family genes and epigenome deregulationSemantic proximity Read

Melanoma genomics - will we go beyond BRAF in clinics?Semantic proximity Read